By interfering with the SHP2/MAPK axis and applying global omics approaches, our study brings new insights into how SHP2 influences IL-8 secretion in different breast cancer cell lines and thereby promotes breast cancer progression. The gene discussed is CXCL8; the disease is breast carcinoma.